Clinical trial
A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate…
NCT00048152 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00048152 |
|---|---|
| Title | A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients |
| Official title | A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Corticosteroids, Neoral, Zenapax, mycophenolate mofetil [CellCept] |
| Enrollment | 539 |
| Start date | Dec 1, 2000 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Oct 25, 2002 |
| Last update posted | Nov 2, 2016 |
| Countries | Australia, Belgium, Canada, France, Germany, Mexico, Norway, Poland, Spain, Sweden, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: